I just bought another parcel on top of recent additions through SPP and on-market. For those who believe in this company, come Q4 with some good news we anticipate, this is a bargain price (despite x2 my own average) let alone when in 2022 we get some results that are pretty much stamping out our position in the Immuno-oncology. But like we know that will be too late to jump on board at the bargain price. Plus or minus 20% is all the same for those who have their eyes on the prize. Of course I may well be wrong but hey, I am only putting my own money on this and not advising here.
Ann: Overall Survival data from ph IIb AIPAC breast cancer trial, page-241
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.010(3.08%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.0¢ | $584.2K | 1.787M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 311433 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 113721 | 6 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |